Abstract
AbstractDeletion of the maternal UBE3A allele causes Angelman syndrome (AS); because paternal UBE3A is epigenetically silenced by a long non-coding antisense (UBE3A-ATS) in neurons, this nearly eliminates UBE3A protein in the brain. Reactivating paternal UBE3A holds promise for treating AS. We previously showed topoisomerase inhibitors can reactivate paternal UBE3A, but their therapeutic challenges prompted our search for small molecule unsilencers with a different mechanism of action. Here, we found that (S)-PHA533533 acts through a novel mechanism to significantly increase paternal Ube3a mRNA and UBE3A protein levels while downregulating Ube3a-ATS in primary neurons derived from AS model mice. Furthermore, peripheral delivery of (S)-PHA533533 in AS model mice induces widespread neuronal UBE3A expression. Finally, we show that (S)-PHA533533 unsilences paternal UBE3A in AS patient-derived neurons, highlighting its translational potential. Our findings provide a lead for developing a small molecule treatment for AS that could be safe, non-invasively delivered, and capable of brain-wide unsilencing of paternal UBE3A.
Funder
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development
Simons Foundation
Angelman Syndrome Foundation
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Petersen, M. B., Brøndum-Nielsen, K., Hansen, L. K. & Wulff, K. Clinical, cytogenetic, and molecular diagnosis of Angelman syndrome: estimated prevalence rate in a Danish county. Am. J. Med. Genet. 60, 261–262 (1995).
2. Mertz, L. G. B. et al. Angelman syndrome in Denmark. Birth incidence, genetic findings, and age at diagnosis. Am. J. Med. Genet. A 161A, 2197–2203 (2013).
3. Clayton-Smith, J. & Laan, L. Angelman syndrome: a review of the clinical and genetic aspects. J. Med. Genet. 40, 87–95 (2003).
4. Williams, C. A., Driscoll, D. J. & Dagli, A. I. Clinical and genetic aspects of Angelman syndrome. Genet. Med. 12, 385–395 (2010).
5. Margolis, S. S., Sell, G. L., Zbinden, M. A. & Bird, L. M. Angelman syndrome. Neurother. J. Am. Soc. Exp. Neurother. 12, 641–650 (2015).